Related Experiment Video
Updated: Dec 25, 2025
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
[Balloon sinuplasty in children - Russian first experience]
I V Zyabkin1, N S Grachev2, E P Karpova3
1Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Health of Russia, Moscow, Russia, 117997; Russian Medical Academy for Continuing Professional Education of the Ministry of Health of Russia, Department of Pediatric Otorhinolaryngology, Moscow, Russia, 125993.
Insights
Balloon sinuplasty offers a safe and effective treatment for pediatric chronic rhinosinusitis (CRS), significantly improving quality of life. This procedure can be an alternative to functional endoscopic sinus surgery (FESS) or used in hybrid techniques.
Area of Science:
- Otolaryngology
- Pediatric Surgery
Background:
- Chronic rhinosinusitis (CRS) significantly impacts pediatric quality of life.
- Medical therapy often fails in pediatric CRS cases, necessitating surgical intervention.
- Comparing treatment outcomes for pediatric CRS is crucial for guiding clinical practice.
Purpose of the Study:
- To compare balloon sinuplasty (BSP) and functional endoscopic sinus surgery (FESS) in pediatric CRS patients.
- To evaluate the clinical outcomes and quality of life improvements after BSP and FESS.
- To assess the safety and efficacy of BSP as a standalone or adjunctive procedure.
Main Methods:
- Retrospective study of 47 pediatric patients with refractory CRS.
- Procedures included balloon sinuplasty (55.3%) and hybrid FESS with BSP (44.7%).
- Data collected: perioperative CT Lund-Mackay scores and SN-5 quality of life scores.
Main Results:
- Significant reduction in Lund-Mackay scores at 1 year post-surgery (p<0.05).
- Balloon sinuplasty improved sinus-related quality of life in 93.3% of patients up to 1 year (p<0.05).
- Both procedures demonstrated positive clinical outcomes.
Conclusions:
- Balloon sinuplasty is clinically effective and safe for pediatric CRS.
- BSP can serve as an alternative to FESS or be integrated into hybrid techniques.
- BSP may help avoid extensive mucosal trauma and infundibulotomy associated with traditional FESS.
Aim:
To evaluate and compare the clinical outcome and impact of balloon sinuplasty and functional endoscopic sinus surgery (FESS) on the quality of life of pediatric patients and adolescents suffering from chronic rhinosinusitis (CRS).
Material And Methods:
A retrospective study was performed of 47 children with failed medical therapy, who were scheduled for surgery. The first one pediatric balloon sinuplasty was performed by Ilya Zyabkin in Filatov Children's City Hospital on the 30-th of August 2012.They underwent treatment by balloon sinuplasty of selected sinuses in 553% (n=26) cases and hybrid FESS with BSP - in 44.7% (n=21). Data were collected, including perioperative CT Lund-Mackay score and SN-5 quality of life findings.
Results:
Compared with preoperative values, Lund-Mackay scores were significantly lower at 1 year (p<0.05) in 92,3% (n=12) patients after surgery. Moreover, balloon sinuplasty improved sinusrelated quality of life score in 93.3% (n=42) patients for up to 1 year after operation (p<0.05).
Conclusion:
Balloon sinuplasty showed a clinical curative effect in the treatment of children and adolescents with refractory CRS, and was relatively safe by itself. BSP allows to postpone, if necessary, FESS or avoid circular mucosal trauma and infundibulotomy in hybrid FESS with balloon sinuplasty technique.
